drugset / Trial / NCT03735030
Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation
RandomizedCrossoverOpen-labelTreatment
Summary
In the present study, the rate and extent of hCG absorption will be compared between the two treatments in healthy women aged 20 to 45 years.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2019-08-02
- Completion
- 2019-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ovidrel | Protein / enzyme biologic | 6500 iu | Subcutaneous |
| Subject | human chorionic gonadotropin | Protein / enzyme biologic | 10000 iu | Subcutaneous |